Movement Disorders Flashcards
Parkinson’s disease - pathology
*loss of pigmented neurons in the substantia nigra -> decreased dopamine and breakdown of nigrostriatal pathway -> motor symptoms of Parkinson’s disease
*impacts both the direct and indirect pathways, with net effect being LESS CORTICAL ACTIVATION
lewy bodies
*cytoplasmic inclusions containing alpha-synuclein
*found in the highest concentration in the substantia nigra, but also in other areas of the nervous system
*characteristic finding of Parkinson’s disease
Parkinson’s disease - risk factors
*advanced age
*male gender
*industrial-level exposure to pesticides or herbicides
Parkinson’s disease - genetic mutations
*note: 90% of Parkinson’s disease is sporadic; only about 10% is hereditary
*SNCA mutation
*GBA mutation
*PRKN mutation
*LRRK2 mutation
core motor features of Parkinson’s disease
*bradykinesia/hypokinesia (decreased speed and amplitude of movements)
*rigidity
*resting tremor (not a given in PD; can still have parkinson’s w/o a tremor; usually pretty slow speed)
*postural instability
*asymmetry
non-motor features of Parkinson’s disease
*loss of smell (anosmia)
*cognitive changes
*sleep disturbances (REM-behavior disorder; insomnia)
*mood disturbances
*autonomic dysfunction (constipation, orthostatic hypotension, urinary dysfunction)
“red flag” features in Parkinsonism (may indicated atypical parkinsonism)
*symmetry at onset
*early postural instability - PSP, MSA
*early eye movement abnormalities - PSP
*early autonomic dysfunction - MSA
*prominent cerebellar signs - MSA
*early cognitive impairment/hallucinations - DLB
*cortical signs - CBD
*poor response to levodopa
Multiple Systems Atrophy (MSA)
*a type of atypical parkinsonism
*synucleinopathy (more in brainstem and ANS)
*early autonomic dysfunction (orthostatic hypotension, urinary retention, impotence, abnormal sweating)
*MSA-C variant with cerebellar features: ataxia, dysrarthria
*MSA-P variant resembles parkinsons
Dementia with Lewy Bodies (DLB)
*a type of atypical parkinsonism
*synucleinopathy
*signs of dementia within 1 year of parkinsonism onset (psychosis/hallucinations/delusions, fluctuating mental status, autonomic dysfunction)
Progressive Supranuclear Palsy (PSP)
*a type of atypical parkinsonism
*tauopathy (deposition of abnormal tau protein in the brain)
*eye movement abnormalities: initially slow eye movements, then supranuclear vertical gaze palsy
*early postural instability and falls: loss of postural reflexes; backward falls are common
corticobasal degeneration (CBD)
*a type of atypical parkinsonism
*tauopathy (deposition of abnormal tau protein in the brain)
*asymmetric parkinsonism (often strikingly so)
*cortical dysfunction (apraxia, sensory loss, myoclonus, alien limb phenomenon)
treatment of parkinsons disease - medication
*dopamine precursor - carbidopa/levodopa
*others include dopamine agonists, drugs that reduce the breakdown of dopamine, amantidine, or anticholinergics
treatment of parkinson’s disease - lifestyle changes
*EXERCISE - seems to be neuroprotective and slows disease progression
*physical therapy
*occupational therapy
*speech therapy
advanced Parkinson’s disease
*patients ultimately develop medication fluctuations, levodopa doses become more frequent over time
*treatment options: deep brain stimulation, carbidopa/levodopa intestinal gel, MRI-guided focused ultrasound (VIM or GPi)
vascular parkinsonism
*mimic of parkinson’s disease
*more often from gradual accumulation of subcortical microvascular disease - confluent periventricular/subcortical
*T2/FLAIR hyperintensities
*less often from multiple strokes